ROCKVILLE, Md.--(BUSINESS WIRE)--Neuralstem, Inc. (NYSE Amex: CUR) announced today it received a notice of allowance from the U.S. Patent and Trademark Office (USPTO) for a patent on four new chemical entities that boost the generation of new neurons. Patent application 12/049,922, entitled “Use of Fused Nicotinamides to Promote Neurogenesis,” claims four chemical entities and any pharmaceutical composition including them.
